Abacavir and Lamivudine Tablets

Product Description

Abacavir and lamivudine tablets with a strength of 600 mg abacavir and 300 mg lamivudine are a combination medication used in the treatment of HIV infection. Let's break down each component:

1. Abacavir (600 mg) Abacavir is a nucleoside reverse transcriptase inhibitor (NRTI). It works by interfering with the activity of reverse transcriptase, an enzyme that HIV needs to replicate. By inhibiting viral replication, abacavir helps to reduce the viral load in the body and slow down the progression of HIV infection.

2. Lamivudine (300 mg) Lamivudine is also a nucleoside reverse transcriptase inhibitor (NRTI). Like abacavir, it works by inhibiting reverse transcriptase and interfering with HIV replication.

Combining these two medications in a single tablet is a common approach in HIV treatment known as combination therapy or antiretroviral therapy (ART). This combination helps to target HIV at different stages of its replication cycle, reducing the likelihood of the virus developing resistance to any single medication.

As with any antiretroviral medication, it's crucial for individuals taking this combination tablet to adhere to their prescribed dosage regimen consistently. Skipping doses or not taking the medication as directed can lead to treatment failure and the development of drug-resistant strains of HIV.

Patients should also be aware of potential side effects associated with these medications, which can include nausea, vomiting, diarrhea, headache, and rash. Additionally, some antiretroviral drugs, including abacavir and lamivudine, have been associated with rare but serious side effects such as hypersensitivity reactions (especially with abacavir) and mitochondrial toxicity (especially with long-term use of NRTIs).

Close monitoring by healthcare providers is essential to manage any side effects and ensure the effectiveness of treatment. It's important for individuals living with HIV to work closely with their healthcare providers to develop a comprehensive treatment plan tailored to their specific needs and circumstances.

Convenient Fixed-Dose Combination

Abacavir and Lamivudine Tablets simplify HIV treatment by combining two potent antiretrovirals into a single tablet, allowing for once-daily dosing. This improves adherence and reduces pill burden compared to separate medications. The combination is recommended for use with other antiretroviral agents, under the supervision of a healthcare provider.


Reliable Quality for Global Markets

Produced in India to strict pharmaceutical standards, these tablets are available to dealers, distributors, exporters, retailers, suppliers, traders, and wholesalers. Packaging options include tamper-evident blister packs or HDPE bottles. Export orders can be fulfilled in accordance with supplier minimum order quantities, ensuring consistent supply for international clients.